Fosrenol (Shire US Manufacturing Inc.)


Welcome to the PulseAid listing for the Fosrenol drug offered from Shire US Manufacturing Inc.. This Phosphate Binder [EPC],Phosphate Chelating Activity [MoA] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: Shire US Manufacturing Inc.
NON-PROPRIETARY NAME: lanthanum carbonate
SUBSTANCE NAME: LANTHANUM CARBONATE
TYPE: HUMAN PRESCRIPTION DRUG
PHARMA CLASS: Phosphate Binder [EPC],Phosphate Chelating Activity [MoA]
ROUTE: ORAL
DOSAGE FORM: POWDER
MARKETING CATEGORY NAME: NDA
START MARKETING DATE: 2014-09-24
END MARKETING DATE: 0000-00-00


Fosrenol HUMAN PRESCRIPTION DRUG Details:

Item DescriptionFosrenol from Shire US Manufacturing Inc.
LABELER NAME: Shire US Manufacturing Inc.
DEA SCHEDULE:
ACTIVE STRENGTH: 750(mg/1)
START MARKETING DATE: 2014-09-24
END MARKETING DATE: 0000-00-00
PRODUCT ID: 54092-256_2dc7bdc7-5d2c-57ee-e054-00144ff8d46c
PRODUCT NDC: 54092-256
APPLICATION NUMBER: NDA204734

Other LANTHANUM CARBONATE Pharmaceutical Manufacturers / Labelers:

Manufacturer / LabelerProprietary Name
Avera McKennan HospitalFosrenol
Cardinal HealthFosrenol
Lupin Pharmaceuticals, Inc.Lanthanum Carbonate
Prasco LaboratoriesLanthanum carbonate
Shire US Manufacturing Inc.Fosrenol